Michael Scolaro

Michael Scolaro

Nov 01, 2017

Group 6 Copy 22
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Impact of Soylent Consumption on Human Microbiome Composition

    As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

    A randomized and controlled trial to examine the impact of lingual frenotomy on bottle feeding mechanics

    Some babies are born with tongue-tie where an unusually short or tight band of tissue tethers the bottom...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Backer Badge Funded